Clinical Trials
59 trialsHAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer
Shanghai Zhongshan Hospital
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma
Case Comprehensive Cancer Center
SELECT-CAR-NK
Essen Biotech
EBNK-ST-001
Essen Biotech
EMITT-1
Grey Wolf Therapeutics
Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation
The First Affiliated Hospital of Xiamen University
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Thomas Jefferson University
IL15-TransDC
University Hospital, Antwerp
MacroTrans
University Health Network, Toronto
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
University of Rochester
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
Big Ten Cancer Research Consortium
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Alliance for Clinical Trials in Oncology
LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery
Washington University School of Medicine
ECT-HCC
University Medical Centre Ljubljana
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
M.D. Anderson Cancer Center
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
University of Texas Southwestern Medical Center
Stereotactic Radiotherapy (SRT) Liver (COLD 1)
University Health Network, Toronto
Vaccine Therapy in Treating Patients With Liver Cancer
Jonsson Comprehensive Cancer Center
Vaccine Therapy in Treating Patients With Liver Cancer
Jonsson Comprehensive Cancer Center
Safety and Efficiency of γδ T Cell Against Liver Cancer
Fuda Cancer Hospital, Guangzhou
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133
Chinese PLA General Hospital
STUHCCPVTT
Sichuan University
Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer
Fuda Cancer Hospital, Guangzhou
Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Swiss Cancer Institute
TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
M.D. Anderson Cancer Center
Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer
First Affiliated Hospital of Zhejiang University
Resveratrol and Human Hepatocyte Function in Cancer
University of Louisville
RAD001 in Advanced Hepatocellular Carcinoma
Massachusetts General Hospital
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Alliance for Clinical Trials in Oncology
Liver Cancer HepaSphere Combined With Cryosurgery
Fuda Cancer Hospital, Guangzhou
Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer
Fuda Cancer Hospital, Guangzhou
A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients
Peking University Cancer Hospital & Institute
HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer
Fuda Cancer Hospital, Guangzhou
Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Carcinoma
Fuda Cancer Hospital, Guangzhou
Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma
Second Military Medical University
Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient
Fuda Cancer Hospital, Guangzhou
Hepatic Artery Infusion With Oxaliplatin
Medical College of Wisconsin
OXY1A
University of Zurich
A New Track Ablation Device for Liver Biopsy: A Feasibility Study
Samsung Medical Center
HEPATOFLUO
Centre Leon Berard
Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer
Swiss Cancer Institute
Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients
Fuda Cancer Hospital, Guangzhou
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
Southwestern Regional Medical Center
AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma
National Cancer Centre, Singapore
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey